Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
Doxorubicin (DOX) is a potent anti-cancer agent that has garnered great interest in research due to its high efficacy despite dose-limiting toxicities. Several strategies have been exploited to enhance the efficacy and safety profile of DOX. Liposomes are the most established approach. Despite the i...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Livro |
| Publicado em: |
MDPI AG,
2023-03-01T00:00:00Z.
|
| Assuntos: | |
| Acesso em linha: | Connect to this object online. |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Chamada: |
A1234.567 |
|---|---|
| Cópia 1 | Disponível |